Sponsored by:

SECURITY: Six Month vs. 12 Month DAT Following DES Implantation ISAR TRIPLE ACC Legislative Conference 2014 ABSORB II: Everolimus Eluting Bioresorbable Scaffold vs Everolimus PARTNER I: Does TAVR With a Balloon-Expandable Device Impact Care in High-Risk, Aortic Stenosis Patients? Full Coverage of TCT 2014

Featured Videos

Advertisement
Advertisement